Education
About Us
Working with TipRanks
Follow Us
Biogen (BIIB)
NASDAQ:BIIB
Total Valuation
Biogen has a market cap or net worth of $16.86B. The enterprise value is $26.68B.
Market Cap$16.86B
Enterprise Value$26.68B
Share Statistics
Biogen has 146.37M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding146.37M
Owned by Insiders0.16%
Owned by Instutions22.41%
Financial Efficiency
Biogen’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 18.46%.
Return on Equity (ROE)9.76%
Return on Assets (ROA)5.82%
Return on Invested Capital (ROIC)18.46%
Return on Capital Employed (ROCE)23.23%
Revenue Per Employee$1,245,733.07
Profits Per Employee$214,635.108
Employee Count7,605
Asset Turnover0.34
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Biogen is 13.65. Biogen’s PEG ratio is 0.34.
PE Ratio13.65
PS Ratio2.30
PB Ratio1.33
Price to Fair Value1.33
Price to FCF8.86
Price to Operating Cash Flow7.75
PEG Ratio0.34
Income Statement
In the last 12 months, Biogen had revenue of $9.47B and earned $1.63B in profits. Earnings per share was $11.22.
Revenue$9.47B
Gross Profit$7.44B
Operating Income$2.94B
Pretax Income$1.91B
Net Income$1.63B
EBITDA2.29B
Earnings Per Share (EPS)11.22
Cash Flow
In the last 12 months, operating cash flow was $2.88B and capital expenditures -$254.20M, giving a free cash flow of $2.62B billion.
Operating Cash Flow$2.88B
Free Cash Flow$2.62B
Free Cash Flow per Share$17.91
Dividends & Yields
Biogen pays an annual dividend of $22.23, resulting in a dividend yield of
Dividend Per Share$22.23
Dividend Yield
Payout Ratio
Free Cash Flow Yield11.29%
Earnings Yield7.33%
Stock Price Statistics
Beta0.57
52-Week Price Change-41.48%
50-Day Moving Average137.88
200-Day Moving Average172.73
Relative Strength Index (RSI)29.57
Average Volume (3m)1.91M
Important Dates
Biogen upcoming earnings date is May 1, 2025, Before Open.
Last Earnings DateFeb 12, 2025
Next Earnings DateMay 1, 2025
Ex-Dividend DateFeb 2, 2017
Financial Position
Biogen as a current ratio of 1.35, with Debt / Equity ratio of 0.40
Current Ratio1.35
Quick Ratio0.90
Debt to Market Cap0.30
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Biogen has paid $273.70M in taxes.
Income Tax$273.70M
Effective Tax Rate14.37%
Enterprise Valuation
Biogen EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 10.55.
EV to Sales2.74
EV to EBITDA0.00
EV to Free Cash Flow10.55
EV to Operating Cash Flow9.23
Balance Sheet
Biogen has $2.38B in cash and marketable securities with $4.88B in debt, giving a net cash position of $2.51B billion.
Cash & Marketable Securities$2.38B
Total Debt$4.88B
Net Cash$2.51B
Net Cash Per Share$17.13
Tangible Book Value Per Share$3.75
Margins
Gross margin is 100.00%, with operating margin of 54.06%, and net profit margin of 16.87%.
Gross Margin100.00%
Operating Margin54.06%
Pretax Margin19.70%
Net Profit Margin16.87%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Biogen is $185.04, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$185.04
Price Target Upside60.67%
Analyst ConsensusModerate Buy
Analyst Count29
Revenue Growth Forecast-1.60%
EPS Growth Forecast39.71%